These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31295174)

  • 21. Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353.
    Bryson YJ; Mirochnick M; Stek A; Mofenson LM; Connor J; Capparelli E; Watts DH; Huang S; Hughes MD; Kaiser K; Purdue L; Asfaw Y; Keller M; Smith E;
    HIV Clin Trials; 2008; 9(2):115-25. PubMed ID: 18474496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus.
    Ugwu EO; Eleje GU; Ugwu AO; Nwagha UI; Ikechebelu JI; Umeh UA; Okafor HU
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD013653. PubMed ID: 37306558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nucleoside reverse transcriptase inhibitor backbones and pregnancy outcomes.
    European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) Study Group
    AIDS; 2019 Feb; 33(2):295-304. PubMed ID: 30562172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission.
    Short CE; Douglas M; Smith JH; Taylor GP
    HIV Med; 2014 Apr; 15(4):233-8. PubMed ID: 24025074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiretroviral therapy for pregnant women living with HIV or hepatitis B: a systematic review and meta-analysis.
    Siemieniuk RA; Foroutan F; Mirza R; Mah Ming J; Alexander PE; Agarwal A; Lesi O; Merglen A; Chang Y; Zhang Y; Mir H; Hepworth E; Lee Y; Zeraatkar D; Guyatt GH
    BMJ Open; 2017 Sep; 7(9):e019022. PubMed ID: 28893758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse perinatal outcomes associated with prenatal exposure to protease-inhibitor-based versus non-nucleoside reverse transcriptase inhibitor-based antiretroviral combinations in pregnant women with HIV infection: a systematic review and meta-analysis.
    Saint-Lary L; Benevent J; Damase-Michel C; Vayssière C; Leroy V; Sommet A
    BMC Pregnancy Childbirth; 2023 Jan; 23(1):80. PubMed ID: 36717801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
    Gibb DM; Kizito H; Russell EC; Chidziva E; Zalwango E; Nalumenya R; Spyer M; Tumukunde D; Nathoo K; Munderi P; Kyomugisha H; Hakim J; Grosskurth H; Gilks CF; Walker AS; Musoke P;
    PLoS Med; 2012; 9(5):e1001217. PubMed ID: 22615543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.
    Staszewski S; Keiser P; Montaner J; Raffi F; Gathe J; Brotas V; Hicks C; Hammer SM; Cooper D; Johnson M; Tortell S; Cutrell A; Thorborn D; Isaacs R; Hetherington S; Steel H; Spreen W;
    JAMA; 2001 Mar; 285(9):1155-63. PubMed ID: 11231744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse perinatal outcomes associated with HAART and monotherapy.
    Portwood C; Murray C; Sexton H; Kumarendran M; Brandon Z; Johnson B; Kirtley S; Hemelaar J
    AIDS; 2022 Aug; 36(10):1409-1427. PubMed ID: 35608111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
    Moodley D; Moodley J; Coovadia H; Gray G; McIntyre J; Hofmyer J; Nikodem C; Hall D; Gigliotti M; Robinson P; Boshoff L; Sullivan JL;
    J Infect Dis; 2003 Mar; 187(5):725-35. PubMed ID: 12599045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection.
    Eron JJ; Yetzer ES; Ruane PJ; Becker S; Sawyer GA; Fisher RL; Tolson JM; Shaefer MS
    AIDS; 2000 Apr; 14(6):671-81. PubMed ID: 10807190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiretroviral therapy during pregnancy and the risk of an adverse outcome.
    Tuomala RE; Shapiro DE; Mofenson LM; Bryson Y; Culnane M; Hughes MD; O'Sullivan MJ; Scott G; Stek AM; Wara D; Bulterys M
    N Engl J Med; 2002 Jun; 346(24):1863-70. PubMed ID: 12063370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maternal nutritional status predicts adverse birth outcomes among HIV-infected rural Ugandan women receiving combination antiretroviral therapy.
    Young S; Murray K; Mwesigwa J; Natureeba P; Osterbauer B; Achan J; Arinaitwe E; Clark T; Ades V; Plenty A; Charlebois E; Ruel T; Kamya M; Havlir D; Cohan D
    PLoS One; 2012; 7(8):e41934. PubMed ID: 22879899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low Immune Activation in Early Pregnancy Is Associated With Preterm But Not Small-for-gestational-age Delivery in Women Infected With Human Immunodeficiency Virus Initiating Antiretroviral Therapy in Pregnancy: A Prematurity Immunology in HIV-infected Mothers and their Infants Study (PIMS) Case-control Study in Cape Town, South Africa.
    Mdletshe N; Thobakgale C; Malaba TR; Madlala H; Myer L; Muema DM; Mogeni P; Gray CM; Altfeld M; Newell ML; Ndung'u T
    Clin Infect Dis; 2021 Dec; 73(12):2205-2216. PubMed ID: 33606024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception.
    Machado ES; Hofer CB; Costa TT; Nogueira SA; Oliveira RH; Abreu TF; Evangelista LA; Farias IF; Mercadante RT; Garcia MF; Neves RC; Costa VM; Lambert JS
    Sex Transm Infect; 2009 Apr; 85(2):82-7. PubMed ID: 18987014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brief Report: Impact of Antiretroviral Regimen on Pregnancy and Infant Outcomes in Women With HIV/ HBV Coinfection.
    Kiweewa FM; Tierney C; Butler K; Peters MG; Vhembo T; Moodley D; Govender V; Mohtashemi N; Ship H; Musoke P; Dula D; George K; Chakhtoura N; Fowler MG; Currier JS; Bhattacharya D
    J Acquir Immune Defic Syndr; 2022 Sep; 91(1):79-84. PubMed ID: 35621877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pregnancy Outcomes of Women Conceiving on Antiretroviral Therapy (ART) Compared to Those Commenced on ART During Pregnancy.
    Theron G; Brummel S; Fairlie L; Pinilla M; McCarthy K; Owor M; Chinula L; Makanani B; Violari A; Moodley D; Chakhtoura N; Browning R; Hoffman R; Fowler MG
    Clin Infect Dis; 2021 Jul; 73(2):e312-e320. PubMed ID: 32564058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study.
    Zash R; Jacobson DL; Diseko M; Mayondi G; Mmalane M; Essex M; Gaolethe T; Petlo C; Lockman S; Holmes LB; Makhema J; Shapiro RL
    Lancet Glob Health; 2018 Jul; 6(7):e804-e810. PubMed ID: 29880310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.